Jubilant Ingrevia (BOM:543271) EBIT: ₹4,189 Mil (TTM As of Mar. 2026)


BOM:543271 Jubilant Ingrevia Ltd BOM:543271
80 GF Score
Price ₹608.75
GF Value ₹698.96
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Jubilant Ingrevia EBIT?

Jubilant Ingrevia BOM:543271 -0.36% 80 EBIT is ₹4,189 Mil as of Mar. 2026. GuruFocus rates BOM:543271 with a GF Score™ of 80/100 and a GF Value™ of ₹698.96 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Jubilant Ingrevia's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹1,235 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4,189 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jubilant Ingrevia's annualized ROC % for the quarter that ended in Mar. 2026 was 8.23%. Jubilant Ingrevia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 12.40%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Jubilant Ingrevia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.12%.


Jubilant Ingrevia  (BOM:543271) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Jubilant Ingrevia's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=4569.2 * ( 1 - 22.62% )/( (0 + 42952.6)/ 1 )
=3535.64696/42952.6
=8.23 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=54837.3 - 9534.5 - ( 2350.2 - max(0, 15917.1 - 20463.8+2350.2))
=42952.6

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Jubilant Ingrevia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=4940.8/( ( (0 + max(0, 0)) + (33023.5 + max(6812.9, 0)) )/ 1 )
=4940.8/( ( 0 + 39836.4 )/ 1 )
=4940.8/39836.4
=12.40 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7825.4 + 8799.6 + 1484.3) - (9534.5 + 0 + 1761.9)
=6812.9

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Jubilant Ingrevia's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=4188.7/101577.849
=4.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jubilant Ingrevia EBIT Related Terms


Jubilant Ingrevia EBIT Historical Data

* Premium members only.

The historical data trend for Jubilant Ingrevia's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jubilant Ingrevia EBIT Chart

Jubilant Ingrevia Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 7,360.34 4,571.07 3,196.15 3,992.50 4,188.70

Jubilant Ingrevia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,156.90 1,124.60 1,050.20 778.70 1,235.20

BOM:543271 vs LIN, SHW, ECL: EBIT Comparison

For the Specialty Chemicals subindustry, Jubilant Ingrevia's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jubilant Ingrevia EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Jubilant Ingrevia's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jubilant Ingrevia's EV-to-EBIT falls into.


BOM:543271
80GF Score
Jubilant Ingrevia Ltd BOM:543271
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jubilant Ingrevia EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,189 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹4,189 Mil mean?
Jubilant Ingrevia (BOM:543271) has a EBIT of ₹4,189 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Jubilant Ingrevia.
Is Jubilant Ingrevia's EBIT too high?
Jubilant Ingrevia's current EBIT is ₹4,189 Mil. Overall, Jubilant Ingrevia has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Ingrevia's EBIT compare to LIN and SHW?
Jubilant Ingrevia's EBIT of ₹4,189 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Jubilant Ingrevia. Jubilant Ingrevia's current EBIT is ₹4,189 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Ingrevia stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Ingrevia (BOM:543271) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹698.96, compared to a current price of ₹608.75 — trading 12.9% below its estimated fair value. The current EBIT is ₹4,189 Mil. Jubilant Ingrevia's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Jubilant Ingrevia (BOM:543271), the current EBIT is ₹4,189 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?

Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be undervalued. The current stock price of ₹608.75 is trading 12.9% below its estimated GF Value™ of ₹698.96. GuruFocus considers Jubilant Ingrevia to be Modestly Undervalued.

Key valuation signals for BOM:543271:

  • EBIT: ₹4,189 Mil
  • GF Value™: ₹698.96 vs. price of ₹608.75 (12.9% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jubilant Ingrevia Business Description

Other Exchanges JUBLINGREA:India
Address 1-A, Sector 16-A, Noida, UP, IND, 201301
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
80GF Score

Get the complete analysis for BOM:543271

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹608.75
Price
₹698.96
GF Value